CANCER CHEMOTHERAPY;
CYCLOSPORINE-A;
FK506;
MULTIDRUG RESISTANCE;
P-GLYCOPROTEIN;
RAPAMYCIN;
D O I:
10.1016/0922-4106(93)90009-X
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
The ability of cyclosporin A, FK506, and rapamycin to overcome multidrug resistance was investigated in Chinese hamster ovary cells in vitro by growth inhibition experiments. 1-30 muM of immunosuppressant sensitized drug-resistant cells and their drug-sensitive parents in a dose-dependent manner to adriamycin (2-2000-fold), colchicine (2-260-fold), and vinblastine (2-120-fold). The multidrug resistance-reversing activity increased in the order rapamycin < FK506 < cyclosporin A, irrespective of whether the resistant cells overexpressed hamster or human P-glycoprotein. The interaction of the three macrolides with P-glycoprotein was characterized by their ability to competitively inhibit the photoaffinity labelling of plasma membranes of resistant CH(R)B30 cells by iodomycin. The three immunosuppressants bound with high affinity to P-glycoprotein.